Reversion of multidrug resistance by tumor targeted delivery of antisense oligodeoxynucleotides in hydroxypropyl-chitosan nanoparticles
Author:
Publisher
Elsevier BV
Subject
Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering
Reference34 articles.
1. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro;Ayman;Eur J Pharm Biopharm,2009
2. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance;Yogesh;J Control Release,2009
3. Shutting down a gene. Antisense drug wins approval;Stix;Sci Am,1998
4. Chemical modification of chitosan as a gene carrier in vitro and in vivo;Kim;Prog Polym Sci,2007
5. Characterization of folate–chitosan–DNA nanoparticles for gene therapy;Mansouri;Biomaterials,2006
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. FTIR determination of the degree of molar substitution for hydroxypropyl chitosan;Carbohydrate Polymers;2024-09
2. Chitosan nanoparticles for gene delivery in cancer therapy and disease diagnosis;Cancer Therapy;2024
3. Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy;Pharmaceutics;2023-03-08
4. Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer;Journal of Nanobiotechnology;2022-09-24
5. Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy;Small;2022-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3